He points to the trial's reported 20% drop in cardiovascular events among people without diabetes and what it could mean for prevention.
Recap by typeshit. Post by @dr.alo on Instagram.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
Moss says he once believed GLP-1s caused far more muscle loss than ordinary calorie cutting. He now says he got that wrong.
Topol points to neoantigens, the proteins or peptides on cancer cell surfaces, as the base of personalized cancer therapies.
STAT
STAT reports that some addiction telehealth platforms now market branded and compounded GLP-1s for alcohol use disorder. Experts warn of fragmented care.
At least half a million Australians use the drugs each month, and experts warn the effects on teenagers are still poorly understood.
Loading…